172 related articles for article (PubMed ID: 10768170)
1. [Comparison of different methods for attenuation correction in brain PET: effect on the calculation of the metabolic rate of glucose].
Setani K; Schreckenberger M; Sabri O; Meyer PT; Zeggel T; Büll U
Nuklearmedizin; 2000; 39(2):50-5. PubMed ID: 10768170
[TBL] [Abstract][Full Text] [Related]
2. Atlas-guided non-uniform attenuation correction in cerebral 3D PET imaging.
Montandon ML; Zaidi H
Neuroimage; 2005 Mar; 25(1):278-86. PubMed ID: 15734362
[TBL] [Abstract][Full Text] [Related]
3. PET/CT: comparison of quantitative tracer uptake between germanium and CT transmission attenuation-corrected images.
Nakamoto Y; Osman M; Cohade C; Marshall LT; Links JM; Kohlmyer S; Wahl RL
J Nucl Med; 2002 Sep; 43(9):1137-43. PubMed ID: 12215550
[TBL] [Abstract][Full Text] [Related]
4. [Investigations on the effect of "ecstasy" on cerebral glucose metabolism: an 18-FDG PET study].
Schreckenberger M; Gouzoulis-Mayfrank E; Sabri O; Arning C; Tuttass T; Schulz G; Kaiser HJ; Wagenknecht G; Sass H; Büll U
Nuklearmedizin; 1998; 37(8):262-7. PubMed ID: 9868707
[TBL] [Abstract][Full Text] [Related]
5. Effects of scatter and attenuation correction on quantitative assessment of regional cerebral blood flow with SPECT.
Iida H; Narita Y; Kado H; Kashikura A; Sugawara S; Shoji Y; Kinoshita T; Ogawa T; Eberl S
J Nucl Med; 1998 Jan; 39(1):181-9. PubMed ID: 9443759
[TBL] [Abstract][Full Text] [Related]
6. Regional cerebral glucose metabolism in healthy volunteers determined by fluordeoxyglucose positron emission tomography: appearance and variance in the transaxial, coronal, and sagittal planes.
Ivançević V; Alavi A; Souder E; Mozley PD; Gur RE; Bénard F; Munz DL
Clin Nucl Med; 2000 Aug; 25(8):596-602. PubMed ID: 10944013
[TBL] [Abstract][Full Text] [Related]
7. Attenuation compensation in cerebral 3D PET: effect of the attenuation map on absolute and relative quantitation.
Zaidi H; Montandon ML; Slosman DO
Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):52-63. PubMed ID: 14574512
[TBL] [Abstract][Full Text] [Related]
8. Whole-body positron emission tomography in clinical oncology: comparison between attenuation-corrected and uncorrected images.
Bengel FM; Ziegler SI; Avril N; Weber W; Laubenbacher C; Schwaiger M
Eur J Nucl Med; 1997 Sep; 24(9):1091-8. PubMed ID: 9283100
[TBL] [Abstract][Full Text] [Related]
9. Validation of postinjection transmission measurements for attenuation correction in neurological FDG-PET studies.
Hooper PK; Meikle SR; Eberl S; Fulham MJ
J Nucl Med; 1996 Jan; 37(1):128-36. PubMed ID: 8543982
[TBL] [Abstract][Full Text] [Related]
10. Multitracer study with positron emission tomography in Creutzfeldt-Jakob disease.
Engler H; Lundberg PO; Ekbom K; Nennesmo I; Nilsson A; Bergström M; Tsukada H; Hartvig P; Långström B
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):85-95. PubMed ID: 12483414
[TBL] [Abstract][Full Text] [Related]
11. One-year follow-up of neuropsychology, MRI, rCBF and glucose metabolism (rMRGlu) in cerebral microangiopathy.
Sabri O; Hellwig D; Schreckenberger M; Schneider R; Kaiser HJ; Wagenknecht G; Setani K; Reinartz P; Zimny M; Mull M; Ringelstein EB; Büll U
Nuklearmedizin; 2000; 39(2):43-9. PubMed ID: 10768169
[TBL] [Abstract][Full Text] [Related]
12. Correlation of neuropsychological, morphological and functional (regional cerebral blood flow and glucose utilization) findings in cerebral microangiopathy.
Sabri O; Hellwig D; Schreckenberger M; Cremerius U; Schneider R; Kaiser HJ; Doherty C; Mull M; Ringelstein EB; Buell U
J Nucl Med; 1998 Jan; 39(1):147-54. PubMed ID: 9443754
[TBL] [Abstract][Full Text] [Related]
13. Quantitative comparison of measurements of cerebral glucose metabolic rate made with two positron cameras.
Grady CL
J Cereb Blood Flow Metab; 1991 Mar; 11(2):A57-63. PubMed ID: 1997489
[TBL] [Abstract][Full Text] [Related]
14. Quantitative comparison of cerebral glucose metabolic rates from two positron emission tomographs.
Grady CL; Berg G; Carson RE; Daube-Witherspoon ME; Friedland RP; Rapoport SI
J Nucl Med; 1989 Aug; 30(8):1386-92. PubMed ID: 2787850
[TBL] [Abstract][Full Text] [Related]
15. Methodologic factors affecting PET measurements of cerebral glucose metabolism.
Jagust WJ; Budinger TF; Huesman RH; Friedland RP; Mazoyer BM; Knittel BL
J Nucl Med; 1986 Aug; 27(8):1358-61. PubMed ID: 3488379
[TBL] [Abstract][Full Text] [Related]
16. [Fundamental evaluation of segmented attenuation correction method for clinical FDG-PET studies: simulation of pulmonary mass lesions in phantom studies].
Matsumoto K; Mori H
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2002 Dec; 58(12):1579-85. PubMed ID: 12577016
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
[TBL] [Abstract][Full Text] [Related]
18. Stability of regional cerebral glucose metabolism in the normal brain measured by positron emission tomography.
Tyler JL; Strother SC; Zatorre RJ; Alivisatos B; Worsley KJ; Diksic M; Yamamoto YL
J Nucl Med; 1988 May; 29(5):631-42. PubMed ID: 3259623
[TBL] [Abstract][Full Text] [Related]
19. Measurement of temporal asymmetries of glucose consumption using linear profiles: reproducibility and comparison with visual analysis.
Matheja P; Diehl B; Kuwert T; Stodieck SR; Schäfers M; Schäfers K; Schuierer G; Ringelstein EB; Schober O
Nuklearmedizin; 1998 Mar; 37(2):43-8. PubMed ID: 9547749
[TBL] [Abstract][Full Text] [Related]
20. Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study.
Feigin A; Leenders KL; Moeller JR; Missimer J; Kuenig G; Spetsieris P; Antonini A; Eidelberg D
J Nucl Med; 2001 Nov; 42(11):1591-5. PubMed ID: 11696626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
